secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apyx Medical Corp (APYX)
CIK:        0000719135
Form:       8-K
Filed at:   2026-08-07T20:00:19+00:00
Accession:  0001493152-26-036557
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apyx shareholders approve 2026 Share Incentive Plan with 4M shares
------------------------------------------------------------------

- Stockholders approved 2026 Share Incentive Plan; 16,186,776 for, 2,755,882 against, 3,276,000 abstain, 7,677,267 broker non-votes.
- Plan authorizes 4,000,000 shares for options and restricted stock to employees, directors, and consultants.
- Five directors elected: Vizirgianakis, Goodwin, Waldman, Baylor-Henry, Levine; all received majority votes.
- Say-on-pay advisory resolution approved: 21,458,554 for, 669,298 against, 90,806 abstain.
- RSM US LLP ratified as independent auditor for FY2026: 29,814,618 for, 31,610 against, 49,697 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/719135/000149315226036557/0001493152-26-036557-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/719135/000149315226036557/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-036557

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer